The Decision That Shapes the Whole Program

Single-use or reusable is not a packaging choice. It determines your materials, your tolerances, your validation program, your cost model, your sales motion, and in many cases your regulatory class. Make it in month one with a written rationale, because reversing it at design freeze usually means starting over. A team that designs a disposable and later decides hospitals want a reusable is not modifying a product; it is building a second one.

Run the decision as four analyses that all have to agree: clinical, engineering, regulatory, and economic. When they disagree, the clinical answer wins and the others adapt.

The Clinical Question: What Happens Between Uses

Start with what the device touches and what it would carry. A device contacting sterile tissue, the bloodstream, or the respiratory tract sits at the top of the Spaulding classification and needs sterilization between uses, not disinfection. A device touching intact skin only may need nothing more than a wipe.

Then ask whether the geometry can actually be cleaned. Long narrow lumens, blind holes, hinges, threaded joints, textured surfaces, and any gap under about 0.02 in (0.5 mm) trap protein and biofilm. Duodenoscope reprocessing failures are the standing example of a geometry that defeated a validated cleaning protocol in real hospital conditions. If you cannot design a lumen that a brush reaches and a flush clears, you are designing a disposable whether you intended to or not.

Finally, consider who reprocesses. A hospital central sterile department has autoclaves, validated washers, and trained staff. An urgent care clinic, a dental office, or a patient's home does not. A reusable aimed at a low-resource setting will be reused improperly.

The Engineering Question: One Cycle or Five Hundred

Disposable design optimizes for unit cost and molding cycle time. You use fewer parts, snap fits instead of screws, commodity resins, and generous tolerances, and you accept that the device never sees a second load cycle. Reusable design optimizes for survival: stainless steel, PEEK, PPSU, silicone, and polycarbonate grades that tolerate repeated steam or chemical exposure, sealed enclosures rated for immersion, and fasteners that can be torqued repeatedly.

  • Material degradation. Steam at 134 degrees C, hydrogen peroxide plasma, and glutaraldehyde each attack different polymers. Polycarbonate crazes under repeated autoclaving; ABS is out entirely. Confirm the resin against the specific reprocessing chemistry, not the general family.
  • Mechanical fatigue. A device rated for 500 uses needs latches, hinges, and seals qualified past that count with margin, which puts it squarely in material fatigue territory rather than static strength.
  • Sealing. Immersion and pressure cycling during autoclaving is harder on gaskets than field use. Gland design and elastomer choice matter here, and the guidance in O-ring selection and gland design applies directly.
  • Labeling survival. Printed markings and adhesive labels rarely survive hundreds of cycles. Laser marking or molded-in text is the usual answer.

Material selection differs on the biocompatibility axis too, because a reusable device's contact duration accumulates and its surface changes with wear. Run the assessment described in ISO 10993 biocompatibility testing against the end-of-life condition, not the pristine part.

The Regulatory Question: What You Have to Prove

A single-use device requires a validated sterilization process and sterile barrier packaging that holds through shipping and shelf life. The tradeoffs among ethylene oxide, gamma, and steam are covered in medical device sterilization methods, and the choice constrains materials and packaging together.

A reusable device requires all of that for the first shipment plus a validated reprocessing instruction set. That means cleaning validation with worst-case soil, disinfection or sterilization efficacy data, and a simulated-use study proving the device still meets specification after the full claimed number of cycles, run by people representative of actual users. Reprocessing validation typically costs 50,000 to 150,000 USD and takes months, and it is a separate line item from device verification. Both paths feed the same hazard analysis, and the reuse decision generates entirely different hazards on each side, which is why it belongs in ISO 14971 risk management from the first draft.

The Economic Question: Cost per Use, Not Cost per Unit

Compare on cost per procedure over the device's life, including everything.

A disposable at 12 USD per unit with 5,000 procedures per year costs 60,000 USD annually in product, plus disposal. A reusable at 2,400 USD with a 500-use life costs about 4.80 USD per use in amortized capital, but add reprocessing labor at roughly 8 to 20 USD per cycle, sterilizer capacity, tracking, and the replacement units needed to cover turnaround time. In many procedure categories the disposable wins on total cost once labor is honestly counted, which is why so much of the market has moved that direction.

Your own economics differ from the hospital's. A disposable gives recurring revenue and a predictable manufacturing volume; a reusable gives a large upfront sale and then years of silence. Tooling amortization also cuts differently, since disposables justify multi-cavity hardened steel tools that would never pay back at reusable volumes, a calculation laid out in injection molding cost. Value engineering on a disposable pays back thousands of times over, which is why the methods in value engineering earn dedicated effort in this category.

The Hybrid Answer, and Why It Dominates

Most successful designs split the device. A durable reusable handle, console, or drive unit holds the electronics, motors, optics, and battery. A sterile single-use tip, cartridge, sheath, or cutting element carries everything patient-contacting. Surgical staplers, powered handpieces, and most endoscopic tools work this way.

The hybrid buys you a clean reprocessing story, recurring consumable revenue, and a lower-cost capital placement. It costs you an interface: the coupling between the two halves must transmit force, power, or signal reliably, seal against fluid ingress into the reusable half, prevent counterfeit or reused consumables (usually through an authenticated chip or a mechanical single-use lockout), and stay cheap on the disposable side. That interface is normally the hardest engineering in the product, so budget for several prototype iterations of it specifically.

Decide It Deliberately

Projects House runs this analysis at the front of device programs, then designs to the answer, including hybrid architectures and their interfaces. Describe your device, its tissue contact, and the setting it will be used in through our contact form and we will work the four-way comparison with you.